Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood cells were stained with APC Mouse anti-Human CD19 (Cat. No. 555415/561742) and either PerCP-Cy™5.5 Mouse anti-Human CXCR5 (CD185) antibody (Cat. No. 562781; Right Panel) or with a PerCP-Cy™5.5 Rat IgG2b, κ Isotype Control (Cat. No. 550764, Left Panel). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185), or Ig isotype control staining, versus CD19 were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood cells were stained with APC Mouse anti-Human CD19 (Cat. No. 555415/561742) and either PerCP-Cy™5.5 Mouse anti-Human CXCR5 (CD185) antibody (Cat. No. 562781; Right Panel) or with a PerCP-Cy™5.5 Rat IgG2b, κ Isotype Control (Cat. No. 550764, Left Panel). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185), or Ig isotype control staining, versus CD19 were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood cells were stained with APC Mouse anti-Human CD19 (Cat. No. 555415/561742) and either PerCP-Cy™5.5 Mouse anti-Human CXCR5 (CD185) antibody (Cat. No. 562781; Right Panel) or with a PerCP-Cy™5.5 Rat IgG2b, κ Isotype Control (Cat. No. 550764, Left Panel). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185), or Ig isotype control staining, versus CD19 were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood cells were stained with APC Mouse anti-Human CD19 (Cat. No. 555415/561742) and either PerCP-Cy™5.5 Mouse anti-Human CXCR5 (CD185) antibody (Cat. No. 562781; Right Panel) or with a PerCP-Cy™5.5 Rat IgG2b, κ Isotype Control (Cat. No. 550764, Left Panel). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185), or Ig isotype control staining, versus CD19 were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood cells were stained with APC Mouse anti-Human CD19 (Cat. No. 555415/561742) and either PerCP-Cy™5.5 Mouse anti-Human CXCR5 (CD185) antibody (Cat. No. 562781; Right Panel) or with a PerCP-Cy™5.5 Rat IgG2b, κ Isotype Control (Cat. No. 550764, Left Panel). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185), or Ig isotype control staining, versus CD19 were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood cells were stained with APC Mouse anti-Human CD19 (Cat. No. 555415/561742) and either PerCP-Cy™5.5 Mouse anti-Human CXCR5 (CD185) antibody (Cat. No. 562781; Right Panel) or with a PerCP-Cy™5.5 Rat IgG2b, κ Isotype Control (Cat. No. 550764, Left Panel). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185), or Ig isotype control staining, versus CD19 were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The RF8B2 monoclonal antibody specifically binds to the human CXC chemokine receptor, CXCR5. CXCR5 (also known as CD185, BLR-1 NLR and MDR15), a seven transmembrane, G-protein-coupled receptor, is the specific receptor for CXC chemokine, CXCL13/BLC/BCA-1. In peripheral blood, CXCR5 expression is restricted to B lymphocytes and a small subset of CD4+ and CD8+ lymphocytes. The restricted expression pattern of CXCR5 on B cells and follicular T helper cells (Tfh) suggests that this receptor functions as a regulator of B and T cell migration. Stimulation of T cells with anti-CD3 monoclonal antibody leads to the down-regulation of CXCR5.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.